Osq 7mg Tab

OSQ 7MG TAB (Semaglutide)

Name

• Common Name: Semaglutide
• Brand Name: Rybelsus (commonly associated with oral semaglutide)

Composition

• Active Ingredient: Semaglutide 7 mg
• OSQ 7MG TAB contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.

Uses OSQ 7MG TAB is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It works by helping the pancreas release insulin when blood glucose levels are high, reducing sugar production by the liver, and slowing down how quickly food leaves the stomach, which contributes to more stable blood sugar levels. Some patients may also experience weight loss as a secondary effect due to decreased appetite and slowed gastric emptying, though it is not approved solely for weight loss.

Dosage and Administration The typical dosage is 7 mg once daily. It is crucial to take OSQ 7MG TAB on an empty stomach in the morning with no more than 4 ounces of plain water. Do not take it with any other liquids besides water. After taking the tablet, wait at least 30 minutes before eating, drinking, or taking any other oral medications. The tablet should be swallowed whole and not split, crushed, or chewed. If a dose is missed, skip it and take the next dose on the following day; do not double up on doses.

Side Effects

• Common Side Effects: Nausea, vomiting, diarrhea, stomach (abdominal) pain, decreased appetite, and constipation. These typically improve over time as the body adjusts to the medication.
• Serious Side Effects: Risk of thyroid C-cell tumors (including medullary thyroid carcinoma), pancreatitis (severe stomach pain, nausea, vomiting), gallbladder problems, kidney injury, changes in vision (diabetic retinopathy), and hypoglycemia (low blood sugar), especially when used with other diabetes medications like insulin or sulfonylureas.

Precautions OSQ 7MG TAB carries a Boxed Warning regarding the risk of thyroid C-cell tumors. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Use with caution in patients with a history of pancreatitis, kidney disease, or diabetic retinopathy. It is not for use in patients with type 1 diabetes or severe gastroparesis. Alcohol consumption should be limited as it can affect blood sugar levels and increase the risk of hypoglycemia.

Storage Store OSQ 7MG TAB in its original closed container at room temperature (68 °F–77 °F or 20 °C–25 °C) to protect it from moisture. Do not store in the bathroom, and keep it out of reach of children and pets. The blue cap of the Rybelsus bottle contains a drying agent to preserve the tablets.

Here are frequently asked questions and answers regarding OSQ 7MG TAB, which contains semaglutide and is commonly known as Rybelsus:

What is OSQ 7MG TAB (Rybelsus) used for?

OSQ 7MG TAB (Rybelsus) is a prescription medicine containing semaglutide, used along with diet and exercise, to improve blood sugar (glucose) in adults with type 2 diabetes. It helps manage blood sugar levels by addressing issues with insulin production or utilization in the body.

How does OSQ 7MG TAB (Rybelsus) work?

Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the natural GLP-1 hormone in your body. This hormone stimulates the pancreas to release more insulin when blood sugar levels are high, reduces the amount of glucose produced by the liver, and slows down how quickly food leaves the stomach. These actions collectively help lower blood sugar levels and HbA1c.

What is the usual dosage for OSQ 7MG TAB (Rybelsus)?

The typical starting dosage for Rybelsus (formulation R1) is 3 mg once daily for 30 days to help your body adjust to the medicine. After this initial period, the dose is usually increased to 7 mg once daily. If further blood sugar control is needed after at least 30 days on the 7 mg dose, your healthcare professional may increase it to a maximum of 14 mg once daily. It's crucial to take it exactly as prescribed.

What are the possible side effects of OSQ 7MG TAB (Rybelsus)?

Common side effects of Rybelsus can include nausea, vomiting, diarrhea, stomach (abdominal) pain, decreased appetite, and constipation. These are often most common when starting the medication or increasing the dose and may improve over time. More serious side effects, though less common, can include pancreatitis, changes in vision, low blood sugar (hypoglycemia, especially when taken with other diabetes medications), kidney problems, and gallbladder issues. There is also a boxed warning regarding the risk of thyroid C-cell tumors based on animal studies, though it is unknown if this risk applies to humans.

Is OSQ 7MG TAB (Rybelsus) safe during pregnancy or breastfeeding?

It is not known if Rybelsus will harm an unborn baby, and it is generally not recommended during pregnancy unless the potential benefits outweigh the risks. Women who can become pregnant should stop taking Rybelsus at least 2 months before planning a pregnancy due to the long washout period of semaglutide. Breastfeeding is also not recommended during treatment with Rybelsus as it's unknown if the medication passes into breast milk.

Can OSQ 7MG TAB (Rybelsus) be taken with other medications?

Rybelsus can interact with other medications. It can increase the risk of low blood sugar when taken with other drugs that lower blood sugar, such as insulin or sulfonylureas. Your doctor may need to adjust the dosages of these medications. Rybelsus can also affect the absorption of other oral medications because it slows down gastric emptying. It should be taken at least 30 minutes before any other oral medications. Examples of drugs with a narrow safety range that require close monitoring if taken with Rybelsus include warfarin and levothyroxine.

What precautions should be taken when taking OSQ 7MG TAB (Rybelsus)?

Before taking Rybelsus, inform your doctor about your full medical history, especially if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), as Rybelsus is contraindicated in these cases. Precautions are also necessary if you have had pancreatitis, diabetic retinopathy (eye problems), kidney problems, or severe stomach problems like gastroparesis.

What happens if a dose of OSQ 7MG TAB (Rybelsus) is missed?

If you miss a dose of Rybelsus, you should skip the missed dose and take your next dose the following day at your regular scheduled time. Do not take two doses at the same time to make up for a missed dose.

How should OSQ 7MG TAB (Rybelsus) be stored?

Rybelsus tablets should be stored at room temperature, between 68°F to 77°F (20°C to 25°C), in a dry place away from moisture. Keep the tablets in their original closed bottle until you are ready to take one. Do not use a pill organizer or other container, and do not crush, cut, or chew the tablets. It is important to keep the bottle tightly closed as the cap contains a drying agent to maintain the tablets' effectiveness.